TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2

The association between collagen type I alpha (COL1A) and chemoresistance has been verified in cancers. However, the specific role of COL1A2 in gastric cancer (GC) cell resistance to apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor 2, has not been...

Full description

Saved in:
Bibliographic Details
Main Authors: Gang Yu, Wanjing Chen, Xianghua Li, Liang Yu, Yanyan Xu, Qiang Ruan, Yawei He, Yong Wang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2022/5374262
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850218764248809472
author Gang Yu
Wanjing Chen
Xianghua Li
Liang Yu
Yanyan Xu
Qiang Ruan
Yawei He
Yong Wang
author_facet Gang Yu
Wanjing Chen
Xianghua Li
Liang Yu
Yanyan Xu
Qiang Ruan
Yawei He
Yong Wang
author_sort Gang Yu
collection DOAJ
description The association between collagen type I alpha (COL1A) and chemoresistance has been verified in cancers. However, the specific role of COL1A2 in gastric cancer (GC) cell resistance to apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor 2, has not been investigated before. The purpose of this study was to explore the potential factors associated with COL1A2 regulation on GC cell apatinib resistance in vitro. With the aid of the Oncomine database and integrated bioinformatics methods, we identified COL1A2 overexpression in GC and its prognostic value. Mechanistically, the COL1A2 promoter has a distinct H3K27ac modification site and that E1A binding protein p300 (EP300) and twist family bHLH transcription factor 1 (TWIST1) can bind to the COL1A2 promoter, which in turn transcriptionally activated COL1A2 expression. In addition, overexpression of COL1A2 significantly promoted resistance to apatinib in GC cells, but knockdown of EP300 or TWIST1 remarkably inhibited COL1A2 expression and promoted sensitivity of GC cells to apatinib. Our findings demonstrated that the combination of EP300 and TWIST1 has a synergistically regulatory effect on COL1A2 expression, thus contributing to apatinib resistance in GC cells.
format Article
id doaj-art-7aaaf1aae06d49ffb311eb32a0cf39f9
institution OA Journals
issn 2210-7185
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-7aaaf1aae06d49ffb311eb32a0cf39f92025-08-20T02:07:37ZengWileyAnalytical Cellular Pathology2210-71852022-01-01202210.1155/2022/5374262TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2Gang Yu0Wanjing Chen1Xianghua Li2Liang Yu3Yanyan Xu4Qiang Ruan5Yawei He6Yong Wang7Department of General SurgeryDepartment of General SurgeryDepartment of Molecular PathologyDepartment of General SurgeryDepartment of General SurgeryDepartment of General SurgeryDepartment of General SurgeryDepartment of General SurgeryThe association between collagen type I alpha (COL1A) and chemoresistance has been verified in cancers. However, the specific role of COL1A2 in gastric cancer (GC) cell resistance to apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor 2, has not been investigated before. The purpose of this study was to explore the potential factors associated with COL1A2 regulation on GC cell apatinib resistance in vitro. With the aid of the Oncomine database and integrated bioinformatics methods, we identified COL1A2 overexpression in GC and its prognostic value. Mechanistically, the COL1A2 promoter has a distinct H3K27ac modification site and that E1A binding protein p300 (EP300) and twist family bHLH transcription factor 1 (TWIST1) can bind to the COL1A2 promoter, which in turn transcriptionally activated COL1A2 expression. In addition, overexpression of COL1A2 significantly promoted resistance to apatinib in GC cells, but knockdown of EP300 or TWIST1 remarkably inhibited COL1A2 expression and promoted sensitivity of GC cells to apatinib. Our findings demonstrated that the combination of EP300 and TWIST1 has a synergistically regulatory effect on COL1A2 expression, thus contributing to apatinib resistance in GC cells.http://dx.doi.org/10.1155/2022/5374262
spellingShingle Gang Yu
Wanjing Chen
Xianghua Li
Liang Yu
Yanyan Xu
Qiang Ruan
Yawei He
Yong Wang
TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
Analytical Cellular Pathology
title TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
title_full TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
title_fullStr TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
title_full_unstemmed TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
title_short TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
title_sort twist1 ep300 expedites gastric cancer cell resistance to apatinib by activating the expression of col1a2
url http://dx.doi.org/10.1155/2022/5374262
work_keys_str_mv AT gangyu twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2
AT wanjingchen twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2
AT xianghuali twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2
AT liangyu twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2
AT yanyanxu twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2
AT qiangruan twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2
AT yaweihe twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2
AT yongwang twist1ep300expeditesgastriccancercellresistancetoapatinibbyactivatingtheexpressionofcol1a2